Due to a production error, the Editor’s name and affiliation were incorrect in the published article. Instead of “Bojana Popovic, Clinic for Endocrinology, Diabetes and Metabolic Diseases, Clinical Center of Serbia, University of Belgrade, Serbia” the correct name is “Aviral Singh, GenesisCare Australia Pty Ltd, Australia”.
There was also a mistake in the Conflict of Interest statement in the originally published article. A shared affiliation between the author MB and the wrong Editor was erroneously disclosed. The correct statement appears below.
“The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.”
The publisher apologizes for this mistake. The original version of this article has been updated.
Summary
Keywords
NET, PRRT, functional tumors, overall survival, progression free survival
Citation
Frontiers Production Office (2024) Erratum: Predicting the survival probability of functional neuroendocrine tumors treated with peptide receptor radionuclide therapy: Serbian experience. Front. Endocrinol. 15:1369692. doi: 10.3389/fendo.2024.1369692
Received
12 January 2024
Accepted
12 January 2024
Published
22 January 2024
Approved by
Frontiers Editorial Office, Frontiers Media SA, Switzerland
Volume
15 - 2024
Updates
Copyright
© 2024 Frontiers Production Office.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Frontiers Production Office, production.office@frontiersin.org
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.